However, the assertion that brain insulin resistance is a salient feature of aging, T2D and dementias require a careful evaluation of whether brain insulin resistance is identical at the molecular and physiological level to insulin resistance as traditionally defined in peripheral tissues. The gene discussed is INS; the disease is type 2 diabetes mellitus.